| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alector, Inc. (ALEC) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. ALEC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.42M | $4.31M | - | |
| Pres | 501.7K | $892.9K | - | |
| CFO | 374.3K | $666.3K | - | |
| Dir | 128.1K | $228.0K | - | |
| Other | 104.6K | $186.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2020 | Paul Robert77 | Chief Medical Officer | Sale+OE | 8,000 | $28.00 | $224,000.00 | -2.8% | |
| Jan 27, 2020 | Oney Sabah | Chief Business Officer | Sale+OE | 16,667 | $25.07 | $417,860.35 | -1.4% | |
| Jan 23, 2020 | Paul Robert77 | Chief Medical Officer | Sale+OE | 6,000 | $24.32 | $145,919.00 | -1.1% | |
| Jan 22, 2020 | King Robert76 | Chief Development Officer | Sell | 15,000 | $22.01 | $330,150.00 | -1.5% | |
| Jan 15, 2020 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $18.67 | $186,700.00 | -3.5% | |
| Jan 9, 2020 | Orbimed Advisors LLC67 | 10% Owner | Sell | 379,997 | $19.50 | $7,409,941.50 | -3.5% | |
| Dec 26, 2019 | Orbimed Advisors LLC67 | 10% Owner | Sell | 519,385 | $19.66 | $10,209,720.70 | -1.2% | |
| Dec 17, 2019 | Orbimed Advisors LLC67 | 10% Owner | Sell | 954,100 | $18.52 | $17,669,932.00 | -7.7% | |
| Dec 13, 2019 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $20.03 | $200,300.00 | -3.4% | |
| Dec 12, 2019 | Oney Sabah | Chief Business Officer | Sale+OE | 6,810 | $20.13 | $137,068.96 | -1.1% |